tykhr
sign in
free sign up
Corcept Therapeutics Incorporated
Biotechnology
Healthcare
CORT
120 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
80.03
52 week high
114.22
high
84.50
52 week low
0.00
low
79.78
growth
97.21 %
previous Close
80.00
P/E ratio
market cap
7.27 B
div yield
0
usd
Jun 2025
qoq
revenue
194 M
23.67 %
net incoming
34.61 M
70.60 %
eps
0.00 %
71.29 %
eps surprise
55.58 %
net profit margin
17.80 %
4.00 %
operating incoming
26.68 M
680.88 %
net change in cash
12.93 M
134.15 %
cash on hand
103 M
14.39 %
cost of revenue
3.43 M
42.86 %
top